Literature DB >> 2904171

Low degree of DNA polymorphism in the HLA-linked lymphotoxin (tumour necrosis factor beta) gene.

J Partanen1, S Koskimies.   

Abstract

Tumour necrosis factors (TNF) alpha (cachectin) and beta (lymphotoxin) are lymphokines with many biological activities. For example, the molecules regulate the immune system, which is of special interest since the genes for the TNF are located within the human major histocompatibility complex (MHC). The MHC encodes HLA-molecules that play a critical role in the cellular interactions of the immune response. To test whether genetic polymorphism in the TNF genes may be involved in the associations between HLA and autoimmune diseases, we here describe an analysis of DNA polymorphism in the human TNF-beta gene. The results show that the TNF-beta gene has only a low degree of DNA polymorphism, and that this is not associated with HLA antigens showing a strong association with autoimmune-like diseases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904171     DOI: 10.1111/j.1365-3083.1988.tb01454.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  10 in total

Review 1.  Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis.

Authors:  C L Verweij
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

3.  Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p.

Authors:  Jochen Hampe; Henning Frenzel; Muddassar M Mirza; Peter J P Croucher; Andrew Cuthbert; Silvia Mascheretti; Klaus Huse; Matthias Platzer; Stephen Bridger; Birgit Meyer; Peter Nürnberg; Pieter Stokkers; Michael Krawczak; Christopher G Mathew; Mark Curran; Stefan Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

4.  Novel detection of restriction fragment length polymorphisms in the human major histocompatibility complex.

Authors:  S J Cross; S Tonks; J Trowsdale; R D Campbell
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

5.  Novel compound tetra-, dinucleotide microsatellite polymorphism in the tumor necrosis factor/lymphotoxin locus.

Authors:  S J Greenberg; K Fujihara; S M Selkirk; F Yu; T L Du; N Glenister; P Hohmann; M H Rickert; P O Spence; C E Miller; L D Jacobs
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

6.  Linkage of inflammatory bowel disease to human chromosome 6p.

Authors:  J Hampe; S H Shaw; R Saiz; N Leysens; A Lantermann; S Mascheretti; N J Lynch; A J MacPherson; S Bridger; S van Deventer; P Stokkers; P Morin; M M Mirza; A Forbes; J E Lennard-Jones; C G Mathew; M E Curran; S Schreiber
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

7.  Polymorphism of tumour necrosis factor-alpha (TNF-alpha) at position -308 in relation to ankylosing spondylitis.

Authors:  G M Verjans; B M Brinkman; C E Van Doornik; A Kijlstra; C L Verweij
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

8.  Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes.

Authors:  C V Jongeneel; L Briant; I A Udalova; A Sevin; S A Nedospasov; A Cambon-Thomsen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

9.  Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production.

Authors:  G Messer; U Spengler; M C Jung; G Honold; K Blömer; G R Pape; G Riethmüller; E H Weiss
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

10.  TNFB gene polymorphism in patients with systemic lupus erythematosus in Korean.

Authors:  H Y Kim; S H Lee; H I Yang; S H Park; C S Cho; T G Kim; H Han; D J Kim
Journal:  Korean J Intern Med       Date:  1995-07       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.